Cargando…
Dengue Virus Infection-Enhancing Activity in Serum Samples with Neutralizing Activity as Determined by Using FcγR-Expressing Cells
BACKGROUND: Progress in dengue vaccine development has been hampered by limited understanding of protective immunity against dengue virus infection. Conventional neutralizing antibody titration assays that use FcγR-negative cells do not consider possible infection-enhancement activity. We reasoned t...
Autores principales: | Moi, Meng Ling, Lim, Chang-Kweng, Chua, Kaw Bing, Takasaki, Tomohiko, Kurane, Ichiro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3289619/ https://www.ncbi.nlm.nih.gov/pubmed/22389741 http://dx.doi.org/10.1371/journal.pntd.0001536 |
Ejemplares similares
-
Genotype-specific and cross-reactive neutralizing antibodies induced by dengue virus infection: detection of antibodies with different levels of neutralizing activities against homologous and heterologous genotypes of dengue virus type 2 in common marmosets (Callithrix jacchus)
por: Azami, Nor Azila Muhammad, et al.
Publicado: (2018) -
Human antibody response to dengue virus: implications for dengue vaccine design
por: Moi, Meng Ling, et al.
Publicado: (2016) -
Japanese encephalitis vaccine-facilitated dengue virus infection-enhancement antibody in adults
por: Saito, Yuka, et al.
Publicado: (2016) -
Importation of Dengue Virus Type 3 to Japan from Tanzania and Côte d’Ivoire
por: Moi, Meng Ling, et al.
Publicado: (2010) -
Genotype-Dependent Immunogenicity of Dengue Virus Type 2 Asian I and Asian/American Genotypes in Common Marmoset (Callithrix jacchus): Discrepancy in Neutralizing and Infection-Enhancing Antibody Levels between Genotypes
por: Azami, Nor Azila Muhammad, et al.
Publicado: (2021)